China Inhalation Therapy Devices Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the China Inhalation Therapy Devices Market was valued at USD 997.0 million in 2025 and is projected to reach USD 1,421.69 million by 2032, growing at a CAGR of approximately 5.2% during 2026–2032.
China Inhalation Therapy Devices Market Highlights
| Report Metric | Details |
| Report Name | China Inhalation Therapy Devices Market |
| Market Size 2025 | USD 997.0 million |
| Market Size 2032 | USD 1,421.69 million |
| Absolute Growth 2025–2032 | USD 424.69 million |
| CAGR 2026–2032 | 5.2% |
| Peak Annual Growth | 7.5% in 2031 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Device Type, 2025 | Nebulizers (41% share) |
| Leading Inhalation Method, 2025 | Compressor / Ultrasonic (49% share) |
| Leading Patient Use Case, 2025 | Chronic Use (49% share) |
| Leading Distribution Channel, 2025 | Hospitals & Retail (50% share) |
| Fastest-Growing Device Type | Dry Powder Inhalers (6.7% CAGR) |
| Fastest-Growing Inhalation Method | Breath-Activated (7.2% CAGR) |
| Fastest-Growing Patient Use Case | Pediatric & Elderly (8.0% CAGR) |
| Fastest-Growing Distribution Channel | Homecare Medical Suppliers (6.7% CAGR) |
| Growing Sector | Homecare Medical Solutions |
| Key End Users | Hospitals, Clinics, Homecare Medical Suppliers, Pharmacies |
China Inhalation Therapy Devices Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Annual growth estimates for each year appear below with the principal reason behind them, explaining the shifts that set the pace of the market.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 4.2 | The market experienced steady growth, driven by increasing respiratory disease prevalence and the 'Healthy China 2030' initiative. |
| 2023 | 5.8 | Demand surged due to the implementation of new asthma management guidelines by the National Health Commission. |
| 2024 | 5.2 | Growth slowed as competition intensified among inhalation device manufacturers and cost pressures emerged. |
| 2025 | 4.8 | Market expansion continued but at a reduced pace amid rising costs and regulatory adjustments. |
| 2026 | 5.0 | An increase in health awareness is expected to contribute to a rebound in growth rates. |
| 2027 | 3.2 | Growth is projected to decelerate as the market adjusts to new regulatory standards. |
| 2028 | 7.1 | Demand is expected to accelerate due to heightened pollution levels in urban areas. |
| 2029 | 4.2 | Market growth is projected to slow as manufacturers face supply chain challenges and rising costs. |
| 2030 | 3.7 | Growth will continue to moderate as the market stabilises post-peak. |
| 2031 | 7.5 | The market is expected to peak with strong demand from hospitals and retail sectors. |
| 2032 | 5.8 | Growth is projected to slow as the market reaches a more mature phase. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
China Inhalation Therapy Devices Market Synopsis
Inhalation Therapy Devices in China encompasses medical instruments designed to deliver medication directly to the lungs. These devices, made from plastic and metal, are essential for treating respiratory conditions such as asthma and COPD. The market for Inhalation Therapy Devices is expanding due to rising pollution levels, the prevalence of respiratory diseases, and government initiatives like the 'Healthy China 2030' programme, which aims to improve respiratory health across the nation. Hospitals and homecare medical suppliers are key buyer groups driving this demand.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Rising prevalence of respiratory diseases drives demand for effective treatment solutions. | Driver | High | Chronic Use |
| Increased health awareness among the population creates a need for inhalation therapy devices. | Driver | High | Pediatric & Elderly |
| Growing demand for portable inhalation devices presents opportunities for suppliers. | Opportunity | High | Dry Powder Inhalers |
| The expansion of homecare medical suppliers is an emerging market opportunity. | Opportunity | Medium | Homecare Medical Suppliers |
| Regulatory hurdles can delay the introduction of new inhalation devices. | Restraint | High | Compressor / Ultrasonic |
| Cost pressures from raw materials can impact pricing strategies for manufacturers. | Restraint | Medium | Metered-Dose Inhalers |
| Supply chain disruptions can lead to delays in device availability for hospitals. | Challenge | High | Hospitals & Retail |
| Intense competition among manufacturers can limit market share for new entrants. | Challenge | Medium | Medical Equipment Vendors |
Evaluation of Drivers in China Inhalation Therapy Devices Market (2026–2032)
The factors lifting demand, and the evidence behind each, are summarised below.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Increasing prevalence of COPD and asthma drives demand for inhalation devices. | Nebulizers | In 2022, approximately 8.6% of adults in China were affected by COPD, increasing the need for effective treatment. |
| Health awareness campaigns promote the use of inhalation therapy devices. | Dry Powder Inhalers | The 'Healthy China 2030' initiative aims to improve respiratory health, boosting device adoption. |
| Rising pollution levels in urban areas increase respiratory health issues. | Nebulizers | In 2022, urban pollution levels contributed to a higher demand for nebulizers, especially among vulnerable populations. |
| The growth of homecare medical suppliers improves device accessibility. | Homecare Medical Suppliers | In 2023, a subsidy program improved access to inhalation devices for low-income families. |
| Technological advancements in inhalation devices improve user experience. | Metered-Dose Inhalers | ISO 13485 compliance ensures quality, driving demand for reliable inhalation devices. |
Market growth for Inhalation Therapy Devices in China is underpinned by rising prevalence of respiratory diseases, increasing health awareness, and heightened pollution levels. In 2022, approximately 8.6% of adults suffered from COPD, leading to greater demand for effective treatment solutions. Urban pollution has resulted in a rise in the need for nebulizers, particularly among vulnerable populations. The growth of homecare medical suppliers has improved access, allowing more patients to obtain necessary devices.
Evaluation of Restraints in China Inhalation Therapy Devices Market
Below mentioned are some major restraints and their influence on market dynamics.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Regulatory hurdles can delay the approval process for new inhalation devices. | Compressor / Ultrasonic | In 2020, new guidelines established by the State Administration for Market Regulation slowed device introductions. |
| Cost pressures from raw materials affect pricing strategies for manufacturers. | Metered-Dose Inhalers | Rising material costs have led to increased prices, impacting affordability for patients. |
| Supply chain disruptions can lead to device shortages in hospitals. | Hospitals & Retail | Global supply chain issues have delayed the availability of essential inhalation devices. |
| Intense competition among manufacturers can limit market share for new entrants. | Medical Equipment Vendors | The crowded market makes it challenging for new companies to establish a foothold. |
| Limited awareness in rural areas restricts market growth potential. | General Population | Many patients in rural regions remain unaware of available inhalation therapies. |
China Inhalation Therapy Devices Market Challenges
Buyers in the China inhalation therapy market face intense competition, as numerous local and international suppliers vie for a share of the growing demand. This rivalry leads to price reductions, which can erode profit margins for producers and limit their ability to innovate. Rising raw material costs, particularly for plastics and metals, have increased production expenses, compelling suppliers to raise prices, which may deter hospitals from purchasing new inhalation therapy devices. Compliance with ISO 13485 prolongs the approval process for new products, delaying market access and impacting hospitals' ability to provide the latest treatment options.
Trends in the China Inhalation Therapy Devices Market
Four trends stand out in the China Inhalation Therapy Devices Market.
- Shift towards Homecare Medical Solutions: The trend towards homecare medical solutions has gained traction, particularly in urban areas. In 2023, the Ministry of Health's subsidy program aimed to improve access to inhalation devices for 1 million low-income households, indicating a growing focus on homecare.
- Increase in Pediatric Inhalation Devices: The demand for pediatric inhalation devices has surged, driven by rising asthma prevalence among children. In 2022, approximately 5% of children in China were diagnosed with asthma, highlighting the need for tailored inhalation solutions.
- Growth of Dry Powder Inhalers: The market for dry powder inhalers is expanding rapidly, with a projected CAGR of 6.7% from 2026 to 2032. Their ease of use and portability make them increasingly popular among patients, particularly in urban settings.
- Expansion of Distribution Channels: The distribution of inhalation devices is diversifying, with over 20,000 pharmacies in urban areas. This expansion improves accessibility for patients, ensuring they can obtain necessary devices more conveniently.
Investment Opportunities in the China Inhalation Therapy Devices Market
Several openings in the China Inhalation Therapy Devices Market merit attention from investors.
- Invest in Homecare Medical Suppliers: Homecare medical suppliers are increasingly vital for device distribution. Collaborating with local suppliers can improve market penetration and access to inhalation devices, especially given the projected need for 1 million households targeted by subsidy programs.
- Supply Pediatric Inhalation Devices: The pediatric inhalation device segment is set for growth, driven by rising asthma rates among children. Investing in this segment can meet the needs of a vulnerable population, particularly in urban areas where asthma prevalence is high.
- Focus on Nebulizers: The demand for nebulizers is increasing due to urban pollution, which has heightened respiratory issues. Suppliers can target urban healthcare facilities to meet this growing need, especially as pollution levels rise.
- Expand Distribution through Pharmacies: With over 20,000 pharmacies in urban areas, expanding distribution channels is crucial. Establishing partnerships with pharmacies can improve accessibility for patients seeking inhalation devices, ensuring timely treatment.
Government Initiatives in the China Inhalation Therapy Devices Market
The 'Healthy China 2030' plan, launched by the National Health Commission in 2023, aims to improve respiratory health through increased access to inhalation therapy devices. This initiative encourages manufacturers to refine production and distribution strategies, ensuring that devices reach those in need. Furthermore, the updated 'National Essential Medicines List' in 2021 has broadened the availability of inhalation therapies, ensuring that more patients can access necessary treatments. This regulatory support creates a more favourable market environment for inhalation therapy devices.
The State Administration for Market Regulation oversees the implementation of various initiatives, including the subsidy programme for low-income families introduced in 2022. This programme targets 1 million households, facilitating access to inhalation devices for those who may otherwise struggle to afford them. Additionally, the National Health Commission funds health awareness campaigns that promote the use of inhalation therapy devices, further driving market growth. These efforts aim to improve respiratory health outcomes across the country.
Future Insight of the China Inhalation Therapy Devices Market
The inhalation therapy devices market in China is set to undergo significant transformations by 2032, driven by the 'Healthy China 2030' initiative aimed at enhancing respiratory health. Advanced inhalation devices will emerge to address the growing need for effective and user-friendly solutions, particularly for children and the elderly. By 2025, the installed base of inhalation devices in hospitals is projected to exceed 1 million units, reflecting a strong commitment to improving healthcare infrastructure. Government subsidies for homecare suppliers will further improve access to inhalation therapy, ensuring timely treatment for respiratory conditions.
Market Segmentation Analysis
Each segment group is reviewed below, with the leader by share and the fastest grower by CAGR.
By Device Type – Nebulizers Dominated, Dry Powder Inhalers Expected to Grow Fastest
According to Shubham Deep, Research Manager at 6Wresearch, the largest device type category in 2025 was Nebulizers, with a 41% share of total revenue. Nebulizers dominate the market share in China, largely due to their widespread application in hospitals and homes for managing respiratory conditions. With an estimated installed base of over 1 million units in hospitals, they are the preferred option for delivering liquid medication effectively. Dry Powder Inhalers are projected to grow fastest, at a CAGR of 6.7% during 2026–2032. The growth of dry powder inhalers is propelled by their user-friendly design and portability, appealing to an increasing number of patients. As pollution levels escalate in urban areas, the demand for these inhalers is projected to rise sharply, further solidifying their market position. Suppliers should prioritise the promotion and distribution of dry powder inhalers to capitalise on the surging demand in the market.
By Inhalation Method – Compressor / Ultrasonic Dominated, Breath-Activated Expected to Grow Fastest
Compressor / Ultrasonic held a 49% share of the China Inhalation Therapy Devices Market by inhalation method in 2025. Compressor and ultrasonic devices hold the largest market share as they are essential for converting liquid medication into aerosol form, making them a staple in hospitals across China. Their reliability and efficiency in delivering medication contribute to their strong presence. The quickest growth will come from Breath-Activated, forecast to expand at a CAGR of 7.2% between 2026 and 2032. Breath-activated inhalation methods are experiencing rapid growth due to their user-friendly design, which allows patients to release medication effortlessly. This convenience is particularly appealing to those managing chronic respiratory conditions. Suppliers must consider investing in breath-activated technologies to meet the increasing demand for user-friendly inhalation methods.
By Patient Use Case – Chronic Use Dominated, Pediatric & Elderly Expected to Grow Fastest
Chronic Use accounted for a 49% market share by patient use case in 2025. Chronic use of inhalation therapy devices represents the largest share, as they are essential for patients with long-term respiratory diseases such as COPD. The high prevalence of chronic conditions among the adult population in China sustains this demand, ensuring a steady market for these devices. Pediatric & Elderly is set to record the highest CAGR in this split, 8.0% over 2026–2032. The pediatric and elderly segments are experiencing rapid growth, reflecting the urgent need for effective treatments in these vulnerable groups. With asthma affecting around 5% of children, targeted solutions for these demographics will become increasingly important. Suppliers should develop tailored products for pediatric and elderly patients to address their specific needs and capture this expanding market.
By Distribution Channel – Hospitals & Retail Dominated, Homecare Medical Suppliers Expected to Grow Fastest
In 2025, Hospitals & Retail led the distribution channel split with a 50% share. Hospitals and retail channels command the largest market share, serving as essential access points for inhalation therapy devices. Their established networks ensure timely patient treatment and support, making them vital for effective device distribution. Over 2026–2032, Homecare Medical Suppliers are expected to post the fastest growth, at a CAGR of 6.7%. Homecare medical suppliers are experiencing rapid growth, driven by government initiatives that aim to enhance access to inhalation devices for home use. This trend towards homecare reflects a shift in patient preferences and healthcare delivery, which is likely to continue expanding. Suppliers must strengthen collaborations with homecare medical suppliers to improve distribution and meet the rising demand for inhalation therapy in home settings.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- China Inhalation Therapy Devices Market Outlook
- Market Size of China Inhalation Therapy Devices Market, 2025
- Forecast of China Inhalation Therapy Devices Market, 2032
- Historical Data and Forecast of China Inhalation Therapy Devices Revenues & Volume for the Period 2022 - 2032F
- China Inhalation Therapy Devices Market Trend Evolution
- China Inhalation Therapy Devices Market Drivers and Challenges
- China Inhalation Therapy Devices Price Trends
- China Inhalation Therapy Devices Porter's Five Forces
- China Inhalation Therapy Devices Industry Life Cycle
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Device Type for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Dry Powder Inhalers for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Nebulizers for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Metered-Dose Inhalers for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Soft Mist Inhalers for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Inhalation Method for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Breath-Activated for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Compressor / Ultrasonic for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Propellant-Based for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Mechanical for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Patient Use Case for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Chronic Use for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Pediatric & Elderly for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By General Population for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Respiratory Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Distribution Channel for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Clinics / Pharmacies for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Homecare Medical Suppliers for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Hospitals & Retail for the Period 2022 - 2032F
- Historical Data and Forecast of China Inhalation Therapy Devices Market Revenues & Volume By Medical Equipment Vendors for the Period 2022 - 2032F
- China Inhalation Therapy Devices Import Export Trade Statistics
- Market Opportunity Assessment By Device Type
- Market Opportunity Assessment By Inhalation Method
- Market Opportunity Assessment By Patient Use Case
- Market Opportunity Assessment By Distribution Channel
- China Inhalation Therapy Devices Top Companies Market Share
- China Inhalation Therapy Devices Competitive Benchmarking By Technical and Operational Parameters
- China Inhalation Therapy Devices Company Profiles
- China Inhalation Therapy Devices Key Strategic Recommendations
Market Covered
The report offers an extensive study of the following market segments.
By Device Type
- Dry Powder Inhalers
- Nebulizers
- Metered-Dose Inhalers
- Soft Mist Inhalers
By Inhalation Method
- Breath-Activated
- Compressor / Ultrasonic
- Propellant-Based
- Mechanical
By Patient Use Case
- Chronic Use
- Pediatric & Elderly
- General Population
- Respiratory Therapy
By Distribution Channel
- Clinics / Pharmacies
- Homecare Medical Suppliers
- Hospitals & Retail
- Medical Equipment Vendors
